Latest Conference Articles

Emerging Therapies Show Promise in Treating Metastatic Breast Cancer

Emerging Therapies Show Promise in Treating Metastatic Breast Cancer

March 16th 2021, 1:00pm

Educated Patient® Breast Cancer Summit

An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.

The Future of Adoptive Cellular Therapy in Lung Cancer

The Future of Adoptive Cellular Therapy in Lung Cancer

March 15th 2021, 1:00pm

Educated Patient® Lung Cancer Summit

In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.

Geriatric Assessment and More Inclusive Clinical Trials Needed for Older Adults with Lung Cancer

Geriatric Assessment and More Inclusive Clinical Trials Needed for Older Adults with Lung Cancer

March 12th 2021, 10:00pm

Educated Patient® Lung Cancer Summit

As the population ages, the incidence of older adults being diagnosed with lung cancer is increasing, though data on how to specifically treat this population are lacking.

How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape

How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape

March 11th 2021, 2:00pm

Educated Patient® Breast Cancer Summit

Targeted therapies that attack cancer in a more precise way than traditional chemotherapy are being used more often in the field of breast cancer, but the solution in utilizing them lies within the patient-oncologist relationship, according to an expert from the Massachusetts General Hospital Cancer Center.

Looking at the Big Picture of Small Cell Lung Cancer

Looking at the Big Picture of Small Cell Lung Cancer

March 10th 2021, 7:00pm

Educated Patient® Lung Cancer Summit

An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.

How Patients With Cancer Can Boost Their ‘Mindfulness Muscle’ and Improve Resiliency

How Patients With Cancer Can Boost Their ‘Mindfulness Muscle’ and Improve Resiliency

March 10th 2021, 2:00pm

Educated Patient® Breast Cancer Summit

Mindfulness practices have been associated with improved mental health outcomes in patients with cancer. Here, an expert shares tips on how patients can strengthen their “mindfulness muscle.”

‘Lost in Transition’ After Breast Cancer

‘Lost in Transition’ After Breast Cancer

March 9th 2021, 4:00pm

Educated Patient® Breast Cancer Summit

With more than 4 million breast cancer survivors in the U.S., survivorship care and understanding what happens to patients after surviving is of the utmost importance. An expert explains some side effects survivors may experience and treatments to help.

How One Organization is Helping People Navigate the ‘Pain, Confusion and Chaos’ of a Cancer Diagnosis

How One Organization is Helping People Navigate the ‘Pain, Confusion and Chaos’ of a Cancer Diagnosis

February 23rd 2021, 10:00pm

DONNA Foundation Marathon Weekend

A cancer diagnosis often comes with concerns of what’s next for patients. One concern is how they’re going to afford their treatments. Here, a panel of experts discuss what options are available.

Shattering Myths: How Patients With Cancer Can Become Better Health Advocates

Shattering Myths: How Patients With Cancer Can Become Better Health Advocates

February 23rd 2021, 7:00pm

DONNA Foundation Marathon Weekend

There are two myths that patients with cancer believe when it comes to being health advocates. Here, a panel of experts look to dispel those myths to help patients become better advocates.

Immunotherapy Combinations Offer ‘Hope and Promise’ for Patients with Advanced Renal Cell Carcinoma

Immunotherapy Combinations Offer ‘Hope and Promise’ for Patients with Advanced Renal Cell Carcinoma

February 23rd 2021, 2:00pm

ASCO Genitourinary Symposium

Positive results from the phase 3 CLEAR clinical trial, presented at the 2021 ASCO Genitourinary Cancers Symposium, are just one more dataset that could offer “a sense of hope and promise” for patients with advanced renal cell carcinoma (RCC), says the study’s lead author, Dr. Robert J. Motzer.